文献速递前列腺癌

ETS融合阴性前列腺癌中雄激素受体的独特转录谱

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2018-10-26

本研究基于三个独立前列腺癌数据集共10608例肿瘤,比较ETS融合阳性与阴性肿瘤中雄激素受体(AR)调控转录组的差异。结果显示ETS状态可基于AR调控基因表达将肿瘤分组,ETS阴性肿瘤依赖不同的AR转录程序驱动肿瘤发生,且代谢和非经典WNT通路中ETS依赖性AR靶基因失调与临床结局相关。

要点

  • ETS状态影响AR转录谱,ETS阴性前列腺癌依赖不同的AR程序。
  • AR调控基因表达可基于ETS状态对前列腺癌样本进行分组。
  • 代谢及非经典WNT通路中ETS依赖性AR靶基因失调与临床结局相关。

核心结论

  • ETS状态影响AR的转录谱,ETS阴性前列腺癌肿瘤依赖截然不同的AR依赖性转录程序驱动和维持肿瘤发生。

研究设计与样本

  • 研究分析了三个独立前列腺癌数据集共10608例患者肿瘤,分为ETS阳性(过表达ERG或其他ETS家族成员)和ETS阴性(其他所有前列腺癌),采用FDR校正方法和基因集富集分析(GSEA)进行差异基因表达分析。

主要发现

  • 基于AR依赖基因表达和无监督主成分分析(PCA)模型,AR调控基因表达单独即可在所有数据库中根据ETS状态将前列腺癌样本分组。
  • ETS状态在TCGA数据库(6.9%)和GRID数据库(6.6%)中区分出多个差异表达基因,两个数据库中有413个重叠基因。
  • GSEA显示ETS阴性和ETS阳性肿瘤中富集不同的雄激素响应基因,AR ChIP-seq数据识别出131个以ETS特异性方式调控的直接AR靶基因。
  • 代谢和非经典WNT通路中ETS依赖性AR靶基因的失调与临床结局相关。

临床怎么用

  • 对于ETS融合阴性的前列腺癌患者,AR调控的转录程序与ETS阳性者不同,提示需关注代谢和非经典WNT通路等特定AR靶基因网络,可能为预后判断和个体化治疗提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate cancer (PCa) tumors harboring translocations of ETS family genes with the androgen responsive TMPRSS2 gene (ETS+ tumors) provide a robust biomarker for detecting PCa in approximately 70% of patients. ETS+ PCa express high levels of the androgen receptor (AR), yet PCa tumors lacking ETS fusions (ETS-) also express AR and demonstrate androgen-regulated growth. In this study, we evaluate the differences in the AR-regulated transcriptomes between ETS+ and ETS- PCa tumors. METHODS: 10,608 patient tumors from three independent PCa datasets classified as ETS+ (samples overexpressing ERG or other ETS family members) or ETS- (all other PCa) were analyzed for differential gene expression using false-discovery-rate adjusted methods and gene-set enrichment analysis (GSEA). RESULTS: Based on the expression of AR-dependent genes and an unsupervised Principal Component Analysis (PCA) model, AR-regulated gene expression alone was able to separate PCa samples into groups based on ETS status in all PCa databases. ETS status distinguished several differentially expressed genes in both TCGA (6.9%) and GRID (6.6%) databases, with 413 genes overlapping in both databases. Importantly, GSEA showed enrichment of distinct androgen-responsive genes in both ETS- and ETS+ tumors, and AR ChIP-seq data identified 131 direct AR-target genes that are regulated in an ETS-specific fashion. Notably, dysregulation of ETS-dependent AR-target genes within the metabolic and non-canonical WNT pathways was associated with clinical outcomes. CONCLUSIONS: ETS status influences the transcriptional repertoire of the AR, and ETS- PCa tumors appear to rely on distinctly different AR-dependent transcriptional programs to drive and sustain tumorigenesis.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Berglund AE, Rounbehler RJ, Gerke T, et al. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer. Prostate Cancer Prostatic Dis. 2018. PMID: 30367117. doi:10.1038/s41391-018-0103-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。